MedTech News
.................... by Andrew Celentano
Scientists reveal a new way cancer cells survive DNA damage
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.
Virus from seafood is linked to a persistent eye disease in humans
A virus that typically infects marine animals, such as shrimp and fish, has jumped to humans and is causing chronic eye disease in some people, according to a study published in the journal Nature Microbiology.
InVera Medical Receives FDA Clearance for InVera Infusion Device – a Novel Non-Thermal Catheter for Enhanced Infusion of Sclerosant for Chronic Venous Disease
Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026.
Stereotaxis wins FDA clearance for Synchrony cath lab tech
Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its Synchrony system.
VDyne secures FDA nod to start pivotal trial for tricuspid valve
With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.
FDA grants 510(k) clearance for Allevion Medical’s Vantage system
Vantage’s intuitive three-step workflow, locate, dilate, decompress, enables physicians to perform procedures with consistency.
Detecting multiple cancers and other diseases from a single blood sample
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities simultaneously by analyzing DNA fragments circulating in the bloodstream.
Spinal cord stimulator stays rigid for surgery, then softens inside the body
What if chronic diseases, which are difficult to treat with medicine alone, could be managed with electricity? As “neuromodulation”—a technology that restores bodily balance by sending signals directly to nerves—gains attention, a Korean research team has brought this possibility one step closer to reality.